Investors bet on newer technology and indications for CGTs
The industry is showing enthusiasm for novel technologies that improve safety and carry innovation potential including in vivo CAR-Ts.
Healthcare
Redefining clinical trials in oncology and rare diseases across the Europe
Metagenomi culls 25% of its workforce and replaces CEO in reshuffle
FDA halts uniQure’s plans for Huntington’s disease gene therapy
Sensei to ditch its lead candidate and cut workforce amidst strategic review
FDA gives first approval for recurrent respiratory papillomatosis therapy
Sartorius to invest $3m for minority share in biotech start-up Nanotein
African countries plan shift to healthcare funding autonomy amid aid cuts
